» Articles » PMID: 37753470

Isolation of Epithelial and Stromal Cells from Colon Tissues in Homeostasis and Under Inflammatory Conditions

Abstract

Inflammation of the gastrointestinal tract is a prevalent pathology in diseases such as inflammatory bowel disease (IBD). Currently, there are no therapies to prevent IBD, and available therapies to treat IBD are often sub-optimal. Thus, an unmet need exists to better understand the molecular mechanisms underlying intestinal tissue responses to damage and regeneration. The recent development of single-cell RNA (sc-RNA) sequencing-based techniques offers a unique opportunity to shed light on novel signaling pathways and cellular states that govern tissue adaptation or maladaptation across a broad spectrum of diseases. These approaches require the isolation of high-quality cells from tissues for downstream transcriptomic analyses. In the context of intestinal biology, there is a lack of protocols that ensure the isolation of epithelial and non-epithelial compartments simultaneously with high-quality yield. Here, we report two protocols for the isolation of epithelial and stromal cells from mouse and human colon tissues under inflammatory conditions. Specifically, we tested the feasibility of the protocols in a mouse model of dextran sodium sulfate (DSS)-induced colitis and in human biopsies from Crohn's patients. We performed sc-RNA sequencing analysis and demonstrated that the protocol preserves most of the epithelial and stromal cell types found in the colon. Moreover, the protocol is suitable for immunofluorescence staining of surface markers for epithelial, stromal, and immune cell lineages for flow cytometry analyses. This optimized protocol will provide a new resource for scientists to study complex tissues such as the colon in the context of tissue damage and regeneration. Key features • This protocol allows the isolation of epithelial and stromal cells from colon tissues. • The protocol has been optimized for tissues under inflammatory conditions with compromised cell viability. • This protocol is suitable for experimental mouse models of colon inflammation and human biopsies.

Citing Articles

Dual Role of α-MSH in Colitis Progression: Mediating Neutrophil Differentiation via Bone Marrow.

Liao X, Liu H, Li Y, Zhang W, Dai Q, Wei H J Inflamm Res. 2025; 18:2011-2029.

PMID: 39959638 PMC: 11827500. DOI: 10.2147/JIR.S503621.


Harnessing a Safe Novel Lipid Nanoparticle: Targeted Oral Delivery to Colonic Epithelial and Macrophage Cells in a Colitis Mouse Model.

Mow R, Kuczma M, Shi X, Mani S, Merlin D, Yang C Nanomaterials (Basel). 2024; 14(22).

PMID: 39591041 PMC: 11597058. DOI: 10.3390/nano14221800.

References
1.
Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner H . Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017; 14(10):979-982. PMC: 5764547. DOI: 10.1038/nmeth.4402. View

2.
Parikh K, Antanaviciute A, Fawkner-Corbett D, Jagielowicz M, Aulicino A, Lagerholm C . Colonic epithelial cell diversity in health and inflammatory bowel disease. Nature. 2019; 567(7746):49-55. DOI: 10.1038/s41586-019-0992-y. View

3.
Mahe M, Sundaram N, Watson C, Shroyer N, Helmrath M . Establishment of human epithelial enteroids and colonoids from whole tissue and biopsy. J Vis Exp. 2015; (97). PMC: 4401205. DOI: 10.3791/52483. View

4.
Smillie C, Biton M, Ordovas-Montanes J, Sullivan K, Burgin G, Graham D . Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis. Cell. 2019; 178(3):714-730.e22. PMC: 6662628. DOI: 10.1016/j.cell.2019.06.029. View

5.
Ng S, Shi H, Hamidi N, Underwood F, Tang W, Benchimol E . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017; 390(10114):2769-2778. DOI: 10.1016/S0140-6736(17)32448-0. View